NASDAQ: ADGI - Adagio Therapeutics, Inc.

Yield per half year: 0%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Adagio Therapeutics, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Adagio Therapeutics, Inc.

Adagio Therapeutics, Inc., биофармацевтическая компания, работающая на клинической стадии, занимается открытием, разработкой и коммерциализацией растворов на основе антител для лечения инфекционных заболеваний в США. Его основным кандидатом в продукте является ADG20, нейтрализующее антитело, которое проходит фазу II / III клинических испытаний для лечения и профилактики коронавирусной болезни. Компания заключила соглашение о сотрудничестве с Adimab, LLC в области обнаружения и оптимизации патентованных антител. Adagio Therapeutics, Inc.

more details
была зарегистрирована в 2020 году и базируется в Уолтеме, Массачусетс.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2021-08-06
ISIN US00534A1025
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт https://adagiotx.com
Цена ао 3.48
Change price per day: 0% (3.48)
Change price per week: 0% (3.48)
Change price per month: 0% (3.48)
Change price per 3 month: 0% (3.48)
Change price per half year: 0% (3.48)
Change price per year: 0% (3.48)
Change price per 3 year: +17.97% (2.95)
Change price per year to date: 0% (3.48)
All parameters

Underestimation

Title Value Grade
P/S 149039789.22 1
P/BV 0.99 9
P/E 0 0
EV/EBITDA 0.27 10
Total: 5

Efficiency

Title Value Grade
ROA, % -64.67 0
ROE, % -72 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.0077 10
Total: 9.2

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % -0.1331 0
Yield EPS, % 113.03 10
Total: 3.8
More

Institutions Volume Share, %
Fidelity Management & Research Company LLC 8660033 7.78
Fidelity Management Trust Company 6259052 5.63
Federated Equity Mgmt Co. Of Penn 2552955 2.29
Vanguard Group Inc 1897426 1.71
Federated Global Investment Management Corp 1880515 1.69
Fidelity Investments 1247408 1.12
Meridian 726617 0.65
BlackRock Fund Advisors 700088 0.63
Franklin Advisers, Inc. 500000 0.45
Northern Trust Investments Inc 326293 0.29
Fidelity SelectCo, LLC 326216 0.29
Strategic Advisers LLC 220346 0.2
State Street Global Advisors 212239 0.19
Northern Trust Asset Management 84715 0.08
BlackRock Institutional Trust Company NA 75149 0.07
SEI Investments Management Corp 74210 0.07
BlackRock 68932 0.06
ETF Managers Group, LLC 45353 0.04
Aon Hewitt Investment Consulting, Inc 22037 0.02
EAM Investors, LLC 19051 0.02
BNY Mellon Investment Adviser, Inc. 17807 0.02
DWS Investment S.A. (ETF) 12155 0.01
Pacific Life Fund Advisors LLC (PLFA) 7355 0.01
Fidelity Investments Canada ULC 5620 0.01
SEI 4101 0
BlackRock Asset Management Canada Ltd 3448 0
ProShare Advisors LLC 2688 0
Assenagon Asset Management SA 394 0



Head Job title Payment Year of birth
Dr. Rebecca Dabora Ph.D. Chief Technology & Manufacturing Officer N/A 1960 (65 years)
Mr. David Hering M.B.A. CEO & Director 453.76k 1976 (49 years)
Ms. Laura Walker Ph.D. Co-Founder & Chief Scientific Officer N/A 1985 (40 years)
Ms. Jane Pritchett V. Henderson CFO, Chief Bus. Officer & Treasurer N/A 1966 (59 years)
Ms. Jill Andersen J.D. Chief Legal Officer & Corp. Sec. 580.12k 1973 (52 years)
Dr. Elham Hershberger Pharm.D. Chief Devel. Officer N/A 1968 (57 years)
Mr. Eric W. Kimble M.B.A. Chief Commercial Officer N/A 1968 (57 years)
Mr. Ed Campanaro Sr. VP of Clinical Operations N/A

Address: United States, Waltham. MA, 303 Wyman Street - open in Google maps, open in Yandex maps
Website: https://adagiotx.com